Related Articles
Pathophysiology and mechanisms of primary sarcopenia (Review)
Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review)
Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)
Dysbiosis and liver diseases (Review)
Gut microbiota influences the efficiency of immune checkpoint inhibitors by modulating the immune system (Review)